Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Gia Han Le, Emily S. Gillissie, Taeho Greg Rhee, Bing Cao, Yazen Alnefeesi, Ziji Guo, Joshua D. Di Vincenzo, Muhammad Youshay Jawad, Andrew M. March, Ranuk Ramachandra, Leanna M.W. Lui & Roger S. McIntyre. (2023) Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials. Expert Opinion on Investigational Drugs 32:5, pages 401-415.
Read now
Read now
Muhammad Youshay Jawad, Joshua D. Di Vincenzo, Felicia Ceban, Saja Jaberi, Leanna M.W. Lui, Emily S. Gillissie, Yazen Alnafeesi, Joshua D. Rosenblat & Roger S. McIntyre. (2022) The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis. Expert Opinion on Drug Safety 21:6, pages 841-852.
Read now
Read now
Nefize Yalin & Allan H Young. (2020) Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?. Neuropsychiatric Disease and Treatment 16, pages 1459-1472.
Read now
Read now
Danielle S. Cha, Xinyi Luo, Juhie Ahmed, Larissa Becirovic, Rebekah H. Cha & Roger S. McIntyre. (2019) Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder. Expert Review of Neurotherapeutics 19:9, pages 777-783.
Read now
Read now
Christy L. M. Hui, Bertha S. T. Lam, Edwin H. M. Lee, Sherry K. W. Chan, Wing C. Chang, Y. N. Suen & Eric Y. H. Chen. (2019) A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia. International Review of Psychiatry 31:5-6, pages 441-459.
Read now
Read now
Maju Mathews, Isaac Nuamah, Adam J Savitz, David W Hough, Dean Najarian, Edward Kim & Srihari Gopal. (2018) Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate. Neuropsychiatric Disease and Treatment 14, pages 2807-2816.
Read now
Read now
Ricardo P. Garay, Carlos A. Zarate$suffix/text()$suffix/text(), Thomas Charpeaud, Leslie Citrome, Christoph U. Correll, Ahcène Hameg & Pierre-Michel Llorca. (2017) Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Review of Neurotherapeutics 17:6, pages 593-609.
Read now
Read now
Clément François, Alice Guiraud-Diawara, Christophe Lançon, Pierre Michel Llorca, Ann Hartry, Lene Hammer-Helmich, Djamel A. Zighed, Adrian Tanasescu & Mondher Toumi. (2017) A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting. Journal of Market Access & Health Policy 5:1.
Read now
Read now
Leslie Citrome, Anna Eramo, Clement Francois, Ruth Duffy, Susan N Legacy, Steve J Offord, Holly B Krasa, Stephen S Johnston, Alice Guiraud-Diawara, Siddhesh A Kamat & Patricia Rohman. (2015) Lack of tolerable treatment options for patients with schizophrenia. Neuropsychiatric Disease and Treatment 11, pages 3095-3104.
Read now
Read now
Dawn F. Ionescu, Jerrold F. Rosenbaum & Jonathan E. Alpert. (2015) Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues in Clinical Neuroscience 17:2, pages 111-126.
Read now
Read now
Articles from other publishers (40)
Sheng-Chiang Wang, Jennifer S. Yokoyama, Nian-Sheng Tzeng, Chia-Fen Tsai & Mu-N Liu. 2023.
Syed Nasir Abbas Bukhari. (2022) Consequences of Antipsychotic Medications on Mental Health. Current Drug Safety 17:4, pages 285-293.
Crossref
Crossref
Muhammad Youshay Jawad & Roger S. McIntyre. (2022) Barriers to managing bipolar I disorder with long-acting injectable antipsychotics. European Neuropsychopharmacology 64, pages 4-6.
Crossref
Crossref
Muhammad Youshay Jawad, Shakila Meshkat, Aniqa Tabassum, Andrea Mckenzie, Joshua D. Di Vincenzo, Ziji Guo, Nabiha Batool Musavi, Lee Phan, Felicia Ceban, Angela TH Kwan, Ranuk Ramachandra, Gia Han Le, Rodrigo B. Mansur, Joshua D. Rosenblat, Roger Ho, Taeho Greg Rhee & Roger S. McIntyre. (2022) The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia. CNS Spectrums, pages 1-20.
Crossref
Crossref
Roger S. McIntyre, Martin Alda, Ross J. Baldessarini, Michael Bauer, Michael Berk, Christoph U. Correll, Andrea Fagiolini, Kostas Fountoulakis, Mark A. Frye, Heinz Grunze, Lars V. Kessing, David J. Miklowitz, Gordon Parker, Robert M. Post, Alan C. Swann, Trisha Suppes, Eduard Vieta, Allan Young & Mario Maj. (2022) The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry 21:3, pages 364-387.
Crossref
Crossref
Ersin Hatice Karslioğlu, Zeynep Kolcu, Nisa İrem Karslioğlu & Ali Çayköylü. (2021) Prospective analysis of serum prolactin levels, clinical symptomatology and sexual functions in patients with schizophrenia switched to paliperidone palmitate 3‐monthly from paliperidone palmitate 1‐monthly: Preliminary findings of the first 3 months. Human Psychopharmacology: Clinical and Experimental 37:3.
Crossref
Crossref
Roger S. McIntyre. (2021) Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg. American Journal of Psychiatry 178:12, pages 1130-1132.
Crossref
Crossref
Dania Abu-Naser, Sara Gharaibeh, Ahmad Z. Al Meslamani, Qais Alefan & Renad Abunaser. (2021) Assessment of Extrapyramidal Symptoms Associated with Psychotropics Pharmacological Treatments, and Associated Risk Factors. Clinical Practice & Epidemiology in Mental Health 17:1, pages 1-7.
Crossref
Crossref
Akhil Kottaram, Leigh A. Johnston, Ye Tian, Eleni P. Ganella, Liliana Laskaris, Luca Cocchi, Patrick McGorry, Christos Pantelis, Ramamohanarao Kotagiri, Vanessa Cropley & Andrew Zalesky. (2020) Predicting individual improvement in schizophrenia symptom severity at 1‐year follow‐up: Comparison of connectomic, structural, and clinical predictors. Human Brain Mapping 41:12, pages 3342-3357.
Crossref
Crossref
Bridgette L. Kram, Jennifer M. Schultheis, Shawn J. Kram & Christopher E. Cox. (2018) A Pharmacy-Based Electronic Handoff Tool to Reduce Discharge Prescribing of Atypical Antipsychotics Initiated in the Intensive Care Unit: A Quality Improvement Initiative. Journal of Pharmacy Practice 32:4, pages 434-441.
Crossref
Crossref
Jose E. M. Pereira, Juergen Eckert, Svemir Rudic, Dehong Yu, Richard Mole, Nikolaos Tsapatsaris & Heloisa N. Bordallo. (2019) Hydrogen bond dynamics and conformational flexibility in antipsychotics. Physical Chemistry Chemical Physics 21:28, pages 15463-15470.
Crossref
Crossref
Shaina Musco, Laura Ruekert, Jaclyn Myers, Dennis Anderson, Michael Welling & Elizabeth Ann Cunningham. (2019) Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy. Journal of Clinical Psychopharmacology 39:4, pages 336-343.
Crossref
Crossref
David Kessler, Alison Burns, Debbie Tallon, Glyn Lewis, Stephanie MacNeill, Jeff Round, William Hollingworth, Carolyn Chew-Graham, Ian Anderson, John Campbell, Chris Dickens, Una Macleod, Simon Gilbody, Simon Davies, Tim J Peters & Nicola Wiles. (2018) Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. Health Technology Assessment 22:63, pages 1-136.
Crossref
Crossref
Baybars Veznedaroglu, Nesrin Dilbaz, Ozcan Uzun & Erdal Isik. (2018) TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel. Therapeutic Advances in Psychopharmacology 8:10, pages 271-285.
Crossref
Crossref
Terence A. Ketter, Gary S. Sachs, Suresh Durgam, Kaifeng Lu, Anju Starace, István Laszlovszky & György Németh. (2018) The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study. Journal of Affective Disorders 225, pages 350-356.
Crossref
Crossref
Pierre-Michel Llorca, Christophe Lançon, Ann Hartry, T. Michelle Brown, Dana B. DiBenedetti, Siddhesh A. Kamat & Clément François. (2017) Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications. BMC Psychiatry 17:1.
Crossref
Crossref
Willie Earley, Suresh Durgam, Kaifeng Lu, István Laszlovszky, Marc Debelle & John M. Kane. (2017) Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia. International Clinical Psychopharmacology 32:6, pages 319-328.
Crossref
Crossref
Kim G. Johnson, Adedayo Fashoyin, Ramiro Madden-Fuentes, Andrew J. Muzyk, Jane P. Gagliardi & Mamata Yanamadala. (2017) Discharge Plans for Geriatric Inpatients with Delirium: A Plan to Stop Antipsychotics?. Journal of the American Geriatrics Society 65:10, pages 2278-2281.
Crossref
Crossref
Olga Zivanovic. (2017) Lithium: A classic drug—Frequently discussed, but, sadly, seldom prescribed!. Australian & New Zealand Journal of Psychiatry 51:9, pages 886-896.
Crossref
Crossref
Willie Earley, Suresh Durgam, Kaifeng Lu, Marc Debelle, István Laszlovszky, Eduard Vieta & Lakshmi N. Yatham. (2017) Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies. Journal of Affective Disorders 215, pages 205-212.
Crossref
Crossref
Zuleide M. Ignácio, Gislaine Z. Réus, Helena M. Abelaira, Amanda L. Maciel, Airam B. de Moura, Danyela Matos, Júlia P. Demo, Júlia B.I. da Silva, Fernanda F. Gava, Samira S. Valvassori, André F. Carvalho & João Quevedo. (2017) Quetiapine treatment reverses depressive-like behavior and reduces DNA methyltransferase activity induced by maternal deprivation. Behavioural Brain Research 320, pages 225-232.
Crossref
Crossref
Sunghwan KimSeung-Yup LeeMinSeob KimKyoung-Uk Lee. (2017) Tardive Dystonia Related with Aripiprazole. Psychiatry Investigation 14:3, pages 380.
Crossref
Crossref
Matthew Sussman, Jeffrey Yu, Siddhesh A. Kamat, Ann Hartry, Susan Legacy, Ruth Duffy & Myrlene Sanon Aigbogun. (2017) Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder. Journal of Affective Disorders 207, pages 54-62.
Crossref
Crossref
Debbie Tallon, Nicola Wiles, John Campbell, Carolyn Chew-Graham, Chris Dickens, Una Macleod, Tim J. Peters, Glyn Lewis, Ian M. Anderson, Simon Gilbody, William Hollingworth, Simon Davies & David Kessler. (2016) Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial. Trials 17:1.
Crossref
Crossref
Roger S. McIntyre, Philip Gorwood, Michael E. Thase, Charlie Liss, Dhaval Desai, Ji Chen & Michael Bauer. (2015) Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder. Journal of Clinical Psychopharmacology 35:6, pages 706-710.
Crossref
Crossref
Lavinia Athanasiu, Lisa-Lena H Smorr, Martin Tesli, Jan I Røssberg, Ida E Sønderby, Olav Spigset, Srdjan Djurovic & Ole A Andreassen. (2015) Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. Journal of Psychopharmacology 29:8, pages 884-891.
Crossref
Crossref
Bridgette L. Kram, Shawn J. Kram & Kelli R. Brooks. (2015) Implications of atypical antipsychotic prescribing in the intensive care unit. Journal of Critical Care 30:4, pages 814-818.
Crossref
Crossref
Roger S. McIntyre & Emmanuelle Weiller. (2015) Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study. Advances in Therapy 32:5, pages 429-444.
Crossref
Crossref
Joel Jakobsson, Maria Bjerke, Carl Johan Ekman, Carl Sellgren, Anette GM Johansson, Henrik Zetterberg, Kaj Blennow & Mikael Landén. (2014) Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients. Neuropsychopharmacology 39:10, pages 2349-2356.
Crossref
Crossref
Heidi O'Connor, Nada S. Al-Qadheeb, Alexander C. White, Vishal Thaker & John W. Devlin. (2013) Agitation During Prolonged Mechanical Ventilation at a Long-Term Acute Care Hospital. Journal of Intensive Care Medicine 29:4, pages 218-224.
Crossref
Crossref
Francesco Salvo, Emanuel Raschi, Ugo Moretti, Anita Chiarolanza, Annie Fourrier-Réglat, Nicholas Moore, Miriam Sturkemboom, Fabrizio De Ponti, Elisabetta Poluzzi & Antoine Pariente. (2014) Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation. European Journal of Clinical Pharmacology 70:5, pages 617-625.
Crossref
Crossref
Peter J. Weiden, Leslie Citrome, Gus Alva, Matthew Brams, Ira D. Glick, Richard Jackson, Greg Mattingly, Farid Kianifard, Xiangyi Meng, Linda Pestreich, Marla Hochfeld & Adam Winseck. (2014) A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia. Schizophrenia Research 153:1-3, pages 160-168.
Crossref
Crossref
Roger S. McIntyre, Marie-Josée Filteau, Lawrence Martin, Simon Patry, Andre Carvalho, Danielle S. Cha, Maxime Barakat & Maia Miguelez. (2014) Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach. Journal of Affective Disorders 156, pages 1-7.
Crossref
Crossref
Vladimir M. Kushnir, Pavan Bhat, Reena V. Chokshi, Alexander Lee, Brian B. Borg, Chandra Prakash Gyawali & Gregory S. Sayuk. (2014) The impact of opiate pain medications and psychoactive drugs on the quality of colon preparation in outpatient colonoscopy. Digestive and Liver Disease 46:1, pages 56-61.
Crossref
Crossref
Emanuel Raschi, Elisabetta Poluzzi, Brian Godman, Ariola Koci, Ugo Moretti, Marija Kalaba, Marion Bennie, Corrado Barbui, Bjorn Wettermark, Miriam Sturkenboom & Fabrizio De Ponti. (2013) Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe. PLoS ONE 8:11, pages e81208.
Crossref
Crossref
Dana Ravyn, Vipa Ravyn, Robert Lowney & Henry A. Nasrallah. (2013) CYP450 Pharmacogenetic treatment strategies for antipsychotics: A review of the evidence. Schizophrenia Research 149:1-3, pages 1-14.
Crossref
Crossref
Hee Ryung Wang, Young Sup Woo & Won-Myong Bahk. (2013) Atypical antipsychotics in the treatment of delirium. Psychiatry and Clinical Neurosciences 67:5, pages 323-331.
Crossref
Crossref
Nada S Al-Qadheeb, Heidi H O'Connor, Alexander C White, Aura Neidhardt, Mark Albizati, Bernard Joseph, Russel J Roberts, Robin R Ruthazer & John W Devlin. (2013) Antipsychotic Prescribing Patterns, and the Factors and Outcomes Associated with Their Use, among Patients Requiring Prolonged Mechanical Ventilation in the Long-Term Acute Care Hospital Setting. Annals of Pharmacotherapy 47:2, pages 181-188.
Crossref
Crossref
Jesse M Raiten, Jacob T Gutsche, Jiri Horak & John GT Augoustides. (2013) Critical care management of patients following transcatheter aortic valve replacement. F1000Research 2, pages 62.
Crossref
Crossref
John W. Devlin, Nada S. Al-Qadhee & Yoanna Skrobik. (2012) Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalised patients: A review of data from prospective, randomised studies. Best Practice & Research Clinical Anaesthesiology 26:3, pages 289-309.
Crossref
Crossref